Article Details

Risk of secondary cancers after CAR-T cell therapy low, according to large Stanford Medicine study

Retrieved on: 2024-06-12 21:09:21

Tags for this article:

Click the tags to see associated articles and topics

Risk of secondary cancers after CAR-T cell therapy low, according to large Stanford Medicine study. View article details on hiswai:

Excerpt

This gene encodes instructions for a protein called a chimeric antigen receptor that recognizes and binds to cancer cells; when the protein is made by ...

Article found on: med.stanford.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up